Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel

BACKGROUND: Triple-Negative Breast Cancer (TNBC) is an aggressive and complex subtype of breast cancer. The current biomarkers used in the context of breast cancer treatment are highly dependent on the targeting of oestrogen receptor, progesterone receptor, or HER2, resulting in treatment failure an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Gyeong Back, Kim, Young-Ae, Seo, Jeong-Han, Lee, Hee Jin, Gong, Gyungyub, Park, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607642/
https://www.ncbi.nlm.nih.gov/pubmed/33138797
http://dx.doi.org/10.1186/s12885-020-07399-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607642/
https://www.ncbi.nlm.nih.gov/pubmed/33138797
http://dx.doi.org/10.1186/s12885-020-07399-8

Ejemplares similares